Literature DB >> 17158203

The low-density lipoprotein class A module of the relaxin receptor (leucine-rich repeat containing G-protein coupled receptor 7): its role in signaling and trafficking to the cell membrane.

András Kern1, Alexander I Agoulnik, Gillian D Bryant-Greenwood.   

Abstract

The relaxin receptor (LGR7, relaxin family peptide receptor 1) is a member of the leucine-rich repeat containing G protein-coupled receptors subgroup C. This and the LGR8 (relaxin family peptide receptor 2) receptor are unique in having a low-density lipoprotein class A (LDL-A) module at their N termini. This study was designed to show the role of the LDL-A in LGR7 expression and function. Point mutants for the conserved cysteines (Cys(47) and Cys(53)) and for calcium binding asparagine (Asp(58)), a mutant with deleted LDL-A domain and chimeric LGR7 receptor with LGR8 LDL-A all showed no cAMP response to human relaxins H1 or H2. We have shown that their cell surface delivery was uncompromised. The mutation of the putative N-linked glycosylation site (Asn(36)) decreased cAMP production and reduced cell surface expression to 37% of the wild-type LGR7. All point mutant, chimeric, and wild-type receptor proteins were expressed as the two forms. The immature or precursor form of the receptor was 80 kDa, whereas the mature receptor, delivered to the cell surface was 95 kDa. The glycosylation mutant was also expressed as two forms with appropriately smaller molecular masses. Deletion of the LDL-A module resulted in expression of the mature receptor only. These data suggest that the LDL-A module of LGR7 influences receptor maturation, cell surface expression, and relaxin-activated signal transduction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158203     DOI: 10.1210/en.2006-1086

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

1.  Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism.

Authors:  Andras Kern; Rosie Albarran-Zeckler; Heidi E Walsh; Roy G Smith
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

2.  Characterization of relaxin receptor (RXFP1) desensitization and internalization in primary human decidual cells and RXFP1-transfected HEK293 cells.

Authors:  András Kern; Gillian D Bryant-Greenwood
Journal:  Endocrinology       Date:  2008-12-30       Impact factor: 4.736

Review 3.  Constitutive formation of an RXFP1-signalosome: a novel paradigm in GPCR function and regulation.

Authors:  Michelle L Halls
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

4.  The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2.

Authors:  Daniel J Scott; K Johan Rosengren; Ross A D Bathgate
Journal:  Mol Endocrinol       Date:  2012-09-12

Review 5.  The actions of relaxin on the human cardiovascular system.

Authors:  Mohsin Sarwar; Xiao-Jun Du; Thomas B Dschietzig; Roger J Summers
Journal:  Br J Pharmacol       Date:  2016-07-11       Impact factor: 8.739

6.  Relaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide.

Authors:  Jonathan T McGuane; Julianna E Debrah; Laura Sautina; Yagna P R Jarajapu; Jacqueline Novak; J Peter Rubin; Maria B Grant; Mark Segal; Kirk P Conrad
Journal:  Endocrinology       Date:  2011-05-10       Impact factor: 4.736

Review 7.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

8.  Identification of small-molecule agonists of human relaxin family receptor 1 (RXFP1) by using a homogenous cell-based cAMP assay.

Authors:  Catherine Z Chen; Noel Southall; Jingbo Xiao; Juan J Marugan; Marc Ferrer; Xin Hu; Raisa E Jones; Shu Feng; Irina U Agoulnik; Wei Zheng; Alexander I Agoulnik
Journal:  J Biomol Screen       Date:  2012-12-04

9.  Cloning, expression, and functional characterization of relaxin receptor (leucine-rich repeat-containing g protein-coupled receptor 7) splice variants from human fetal membranes.

Authors:  András Kern; Daniela Hubbard; Aaron Amano; Gillian D Bryant-Greenwood
Journal:  Endocrinology       Date:  2007-12-13       Impact factor: 4.736

10.  Regulation of GPR54 signaling by GRK2 and {beta}-arrestin.

Authors:  Macarena Pampillo; Natasha Camuso; Jay E Taylor; Jacob M Szereszewski; Maryse R Ahow; Mateusz Zajac; Robert P Millar; Moshmi Bhattacharya; Andy V Babwah
Journal:  Mol Endocrinol       Date:  2009-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.